All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WJ1851 | Anti-NUP50 (CBWJN-0301) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJN-0301 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1852 | Anti-NUP50 (CBWJN-1039) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJN-1039 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ1853 | Anti-NUP50 (4H7) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 4H7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1854 | Anti-NUP50 (B-6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | B-6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ1855 | Anti-NUP50 (G-4) h(41BB-CD3ζ) CAR, pCDCAR1 | G-4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4143 | Anti-NUP50 (CBWJN-0301) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJN-0301 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4144 | Anti-NUP50 (CBWJN-1039) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJN-1039 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4145 | Anti-NUP50 (4H7) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 4H7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4146 | Anti-NUP50 (B-6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | B-6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ4147 | Anti-NUP50 (G-4) h(CD28-CD3ζ) CAR, pCDCAR1 | G-4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION